Bulgarian BlackPeak Capital has invested €7 million in Fasal Bio, marking its first direct investment in Croatia. This is the final investment from BlackPeak’s current fund, SE Growth Equity Fund I.
The funding will support the global expansion of Fasal Bio’s proprietary Naturion™ platform, a renewable composite material designed to reduce reliance on fossil-based plastics.
Founded in 2012 and headquartered in Zagreb by plastics engineer Krešimir Hagljan, Fasal Bio has developed Naturion™ as a drop-in solution compatible with existing thermoplastic manufacturing processes such as injection molding and extrusion. This allows manufacturers to adopt renewable materials without investing in new infrastructure.
Scaling Naturion™ for global adoption
The fresh capital will be used to expand production capacity and strengthen the company’s commercial and research capabilities. According to the company, demand for Naturion™ materials already exceeds current output, with customers across the US and Western Europe integrating the material into commercial product lines.
Fasal Bio operates across multiple consumer categories, including animal chewables, children’s toys, household goods, and premium clothing accessories. Its proprietary brands, DBone and FORMIQ, showcase the versatility of its materials platform.
“We are moving from proving what is possible to scaling it globally,” said Hagljan. “With BlackPeak’s support, we are expanding manufacturing and accelerating our mission to enable everyday products to be made from renewable materials at industrial scale.”
Investor perspective
For BlackPeak Capital, the deal aligns with its strategy of backing high-growth companies in Southeast and Central Europe that combine technical innovation with scalable business models.
“Fasal has built a platform where deep technical capability translates into real-world products,” said Marko Dabić, Investment Manager, BlackPeak Capital. “As sustainability commitments shift toward implementation, solutions like this become essential.”
